Malignant Intracranial Pressure Elevation in MOGAD Meningoencephalitis
Open Access
- 11 September 2026
- journal article
- Published by SAGE Publications in Journal of Child Neurology
Abstract
Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) was first proposed as a distinct demyelinating disorder about a decade ago; however, its entire range of phenotypes has yet to be established. We present a case of a 15-year-old boy with features of viral meningoencephalitis with refractory elevated intracranial pressure requiring decompression ultimately diagnosed with an atypical phenotype of MOGAD. After treatment with steroids, 7 rounds of plasmapheresis, intravenous immunoglobulin, and tocilizumab, followed by a second attack and maintenance therapy, he improved to near baseline. Our intention is to raise awareness about the spectrum of less common phenotypes like cerebral cortical encephalitis. We review other atypical MOGAD presentations for comparison. Patients presenting with meningoencephalitis and a negative infectious workup, particularly in the setting of elevated intracranial pressure, should be tested for myelin oligodendrocyte glycoprotein immunoglobulin G as prompt diagnosis and initiation of immunotherapy may improve outcomes and reduce the risk of relapse.Keywords
This publication has 21 references indexed in Scilit:
- Meningitis as an Attack Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseJAMA Neurology, 2025
- MOGAD presenting as fulminant intracranial hypertensionJournal of Neuroimmunology, 2024
- Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaThe Lancet Neurology, 2023
- Cerebral Cortical Encephalitis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated DiseaseAnnals of Neurology, 2022
- Comparison of clinical and radiological characteristics in autoimmune GFAP astrocytopathy, MOGAD and AQP4-IgG+ NMOSD mimicking intracranial infection as the initial manifestationMultiple Sclerosis and Related Disorders, 2022
- Myelin-oligodendrocyte glycoprotein antibody-associated diseaseThe Lancet Neurology, 2021
- The development and impact of cladribine on lymphoid and myeloid cells in multiple sclerosisMultiple Sclerosis and Related Disorders, 2021
- MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrumNeurological Sciences, 2020
- MOG antibody associated demyelinating syndrome presenting as aseptic meningitis in a 6-year-old boyMultiple Sclerosis and Related Disorders, 2020
- Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational studyThe Lancet Neurology, 2020